[{"address1": "665 Stockton Drive", "address2": "Suite 300", "city": "Exton", "state": "PA", "zip": "19341", "country": "United States", "phone": "610 321 3700", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc. operates as a biotechnology company that develops targeted cancer therapies. Its portfolio includes immunotherapies, targeted effectors, radioligand therapies, and antibody drug conjugates (ADCs). The company also offers rapid screening of novel antibodies and targets through memory B cell hybridoma technology. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.", "fullTimeEmployees": 37, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 62, "title": "President, CEO & Chairman", "yearBorn": 1961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 33, "title": "Interim CFO & Executive VP of Operations", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Lapetina", "age": 48, "title": "Principal Accounting Officer", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip  Roberts", "title": "Chief Technical Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 43, "title": "Chief Scientific Officer", "yearBorn": 1980, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 50, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2020, "totalPay": 443432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruce  Turner M.D., Ph.D.", "age": 60, "title": "Chief Strategy Officer", "yearBorn": 1963, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "title": "Chief Medical Officer", "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 48, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2020, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1609372800, "maxAge": 86400, "priceHint": 2, "previousClose": 25.17, "open": 25.4, "dayLow": 25.35, "dayHigh": 26.55, "regularMarketPreviousClose": 25.17, "regularMarketOpen": 25.4, "regularMarketDayLow": 25.35, "regularMarketDayHigh": 26.55, "beta": 1.681, "forwardPE": -16.046297, "volume": 384224, "regularMarketVolume": 384224, "averageVolume": 640033, "averageVolume10days": 668680, "averageDailyVolume10Day": 668680, "bid": 26.28, "ask": 26.4, "bidSize": 800, "askSize": 900, "marketCap": 1486061440, "fiftyTwoWeekLow": 4.18, "fiftyTwoWeekHigh": 27.819, "priceToSalesTrailing12Months": 145.80666, "fiftyDayAverage": 17.6466, "twoHundredDayAverage": 9.870975, "currency": "USD", "enterpriseValue": 985219264, "profitMargins": -2.15443, "floatShares": 30709941, "sharesOutstanding": 57167200, "sharesShort": 3847900, "sharesShortPriorMonth": 1986829, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.084300004, "heldPercentInsiders": 0.2029, "heldPercentInstitutions": 0.40382, "shortRatio": 4.38, "shortPercentOfFloat": 0.0872, "impliedSharesOutstanding": 57167200, "bookValue": 0.498, "priceToBook": 52.1988, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -21958000, "trailingEps": -1.8, "forwardEps": -1.62, "enterpriseToRevenue": 96.666, "enterpriseToEbitda": -44.254, "52WeekChange": 4.799539, "SandP52WeekChange": 0.27220368, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "IMNM", "underlyingSymbol": "IMNM", "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "firstTradeDateEpochUtc": 1601645400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "c2147e86-3bc9-3a00-bf6a-53fc4499717d", "messageBoardId": "finmb_108518404", "gmtOffSetMilliseconds": -18000000, "currentPrice": 25.995, "targetHighPrice": 40.0, "targetLowPrice": 27.0, "targetMeanPrice": 33.5, "targetMedianPrice": 33.5, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 90641000, "totalCashPerShare": 2.121, "ebitda": -22263000, "totalDebt": 350000, "quickRatio": 3.922, "currentRatio": 3.955, "totalRevenue": 10192000, "debtToEquity": 5.76, "revenuePerShare": 0.837, "returnOnAssets": -0.22900999, "returnOnEquity": -1.5060401, "freeCashflow": 8027000, "operatingCashflow": 3208000, "grossMargins": 1.5467, "ebitdaMargins": -2.18436, "operatingMargins": -1.29958, "financialCurrency": "USD", "trailingPegRatio": null}]